Form 8-K - Current report:
SEC Accession No. 0001104659-22-115448
Filing Date
2022-11-07
Accepted
2022-11-07 16:34:33
Documents
12
Period of Report
2022-11-02
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2229891-1_8k.htm   iXBRL 8-K 24244
  Complete submission text file 0001104659-22-115448.txt   197635

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE eyen-20221102_lab.xml EX-101.LAB 34476
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eyen-20221102_pre.xml EX-101.PRE 22595
4 XBRL TAXONOMY EXTENSION SCHEMA eyen-20221102.xsd EX-101.SCH 3033
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2229891-1_8k_htm.xml XML 3698
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38365 | Film No.: 221366012
SIC: 2834 Pharmaceutical Preparations